Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Eamonn Farrell/Photocall Ireland
Jobswatch

Pfizer to create up to 250 construction jobs

Pfizer is expanding its plants in Dublin and Cork to produce pharmaceuticals to deal with some of the most difficult to cure diseases.

PHARMACEUTICAL GIANT PFIZER is to invest €100 million in two manufacturing sites in Ireland, creating an estimated 250 construction jobs.

The company said it is expanding two sites – one in Clondalkin in Dublin and the other in Ringaskiddy in Cork – to produce drugs which will deal with some of the most devastating and difficult to cure diseases.

Construction at the Dublin site is to begin soon, with 140 jobs to be created over the next year with a peak of 250 jobs altogether. The factory will be opened in 2015.

The €23 million euro investment in Ringaskiddy will create new equipment and technology to work on new clinical products.

Minister for Jobs Richard Bruton said the announcement was “confirmation that we are taking the right steps to ensure that Ireland is a key location for companies like Pfizer to expand and grow their business.”

Pfizer opened its first factory in Ireland in the 1970s and currently employs an estimated 3,200 people across six sites in Ireland. The company cut 6,000 jobs worldwide in 2010, with 200 people made unemployed from its plant in Newbridge in Kildare.

Read: Jobs expo targets skilled Irish workers to help with Christchurch rebuild >

Read: Hewlett Packard is cutting 280 jobs at its Dublin office >

Read: Ulster Bank to close 39 branches >

Your Voice
Readers Comments
24
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.